Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women’s health fields, nutritional and over-the-counter pharmaceutical products. The company’s Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women’s health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Johnson & Johnson (NYSE:JNJ)’s Financial Overview

Johnson & Johnson (NYSE:JNJ) declined -0.57% yesterday to close its trading session at $112.48. The company has 1 year Price Target of $126.32. Johnson & Johnson has 52-Week high of $126.07 and 52-Week Low of $94.28. The stock touched its 52-Week High on Jul 20, 2016 and 52-Week Low on Jan 21, 2016. The stock traded with the volume of 7.79 Million shares yesterday. The firm shows the market capitalization of $306.01 Billion.

Johnson & Johnson (NYSE:JNJ) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $1.68/share against the analyst consensus estimate of $1.66/share. The difference between the actual and expected EPS is $0.02 a share with a surprise factor of 1.2%.

The firm is trading with SMA20 of -2.46 Percent, SMA50 of -3.08 Percent and SMA200 of -1.31 percent. Johnson & Johnson has P/S value of 4.27 while its P/B value stands at 4.22. Similarly, the company has Return on Assets of 11.6 percent, Return on Equity of 22.1 percent and Return on Investment of 14.7 Percent. The company shows Gross Margin and Operating Margin of 69.6 percent and 26 percent respectively.

Many brokerage firms are involved in issuing their ratings on Johnson & Johnson (NYSE:JNJ). On 20-May-16 Standpoint Research Initiated Johnson & Johnson Stock  to Sell. Another firm also rated the stock on 14-Mar-16 where Goldman Upgrade the stock to Neutral.

The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 19 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 126.00, with a high estimate of 144.00 and a low estimate of 104.00. The median estimate represents a +12.02% increase from the last price of 112.48.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Marathon Petroleum Corporation (NYSE:MPC)

Marathon Petroleum Corporation is engaged in refining, transporting, and marketing of petroleum products. Marathon Petroleum Corporation is headquartered in Findlay, Ohio.

Marathon Petroleum Corporation (NYSE:MPC)’s Financial Outlook

The 19 analysts offering 12-month price forecasts for Marathon Petroleum have a median target of 54.00, with a high estimate of 59.00 and a low estimate of 42.00. The median estimate represents a +17.44% increase from the last price of 45.98.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Marathon Petroleum Corporation has a Consensus Recommendation of 1.71. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -2.27% and closed its last trading session at $45.98. The company has the market capitalization of $24.27 Billion. The stock has 52-week high of $59.99 and 52-Week low of $29.24. The firm touched its 52-Week high on Dec 2, 2015 and 52-Week low on Feb 9, 2016. The company has volume of 7.76 Million shares. The company has a total of 527.82 Million shares outstanding.

Marathon Petroleum Corporation (NYSE:MPC) in the last quarter reported its actual EPS of $0.58/share where the analyst estimated EPS was $0.81/share. The difference between the actual and Estimated EPS is $-0.23. This shows a surprise factor of -28.4 percent.

The company has YTD performance of -8.02 percent. Beta for Marathon Petroleum Corporation stands at 1.8 while its ATR (average true range) is 1.47. The company has Weekly Volatility of 2.60%% and Monthly Volatility of 3.14%%.

Marathon Petroleum Corporation has distance from 20-day Simple Moving Average (SMA20) of 4.83%, Distance from 50-Day Simple Moving Average of 7.56 percent and Distance from 200-Day Simple Moving Average of 19.42%.

The Company currently has ROA (Return on Assets) of 2.6 percent, Return on Equity (ROE) of 8.5 Percent and Return on Investment (ROI) of 12.6% with Gross margin of 10.1 percent and Operating & Profit margin of 3.5% and 1.8% respectively.

 

SHARE